CSTL
Price
$15.89
Change
-$0.13 (-0.81%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
608.02M
81 days until earnings call
VTAK
Price
$0.21
Change
-$0.09 (-30.00%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
3.41M
Interact to see
Advertisement

CSTL vs VTAK

Header iconCSTL vs VTAK Comparison
Open Charts CSTL vs VTAKBanner chart's image
Castle Biosciences
Price$15.89
Change-$0.13 (-0.81%)
Volume$8.13K
Capitalization608.02M
Catheter Precision
Price$0.21
Change-$0.09 (-30.00%)
Volume$1.51K
Capitalization3.41M
CSTL vs VTAK Comparison Chart
Loading...
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSTL vs. VTAK commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Hold and VTAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CSTL: $16.02 vs. VTAK: $0.30)
Brand notoriety: CSTL and VTAK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 71% vs. VTAK: 1309%
Market capitalization -- CSTL: $608.02M vs. VTAK: $3.41M
CSTL [@Medical Specialties] is valued at $608.02M. VTAK’s [@Medical Specialties] market capitalization is $3.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileVTAK’s FA Score has 2 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • VTAK’s FA Score: 2 green, 3 red.
According to our system of comparison, VTAK is a better buy in the long-term than CSTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 4 TA indicator(s) are bullish while VTAK’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 4 bullish, 4 bearish.
  • VTAK’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VTAK is a better buy in the short-term than CSTL.

Price Growth

CSTL (@Medical Specialties) experienced а -1.84% price change this week, while VTAK (@Medical Specialties) price change was +1.34% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.26%. For the same industry, the average monthly price growth was +6.83%, and the average quarterly price growth was -0.38%.

Reported Earning Dates

CSTL is expected to report earnings on Aug 11, 2025.

VTAK is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Medical Specialties (+0.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSTL($608M) has a higher market cap than VTAK($3.42M). VTAK YTD gains are higher at: -33.038 vs. CSTL (-39.887).
CSTLVTAKCSTL / VTAK
Capitalization608M3.42M17,804%
EBITDA-45.02MN/A-
Gain YTD-39.887-33.038121%
P/E RatioN/AN/A-
Revenue220MN/A-
Total Cash243MN/A-
Total Debt15.3MN/A-
FUNDAMENTALS RATINGS
CSTL vs VTAK: Fundamental Ratings
CSTL
VTAK
OUTLOOK RATING
1..100
421
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9291
P/E GROWTH RATING
1..100
995
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTAK's Valuation (27) in the Medical Specialties industry is somewhat better than the same rating for CSTL (68) in the null industry. This means that VTAK’s stock grew somewhat faster than CSTL’s over the last 12 months.

VTAK's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CSTL (100) in the null industry. This means that VTAK’s stock grew similarly to CSTL’s over the last 12 months.

VTAK's SMR Rating (100) in the Medical Specialties industry is in the same range as CSTL (100) in the null industry. This means that VTAK’s stock grew similarly to CSTL’s over the last 12 months.

VTAK's Price Growth Rating (91) in the Medical Specialties industry is in the same range as CSTL (92) in the null industry. This means that VTAK’s stock grew similarly to CSTL’s over the last 12 months.

VTAK's P/E Growth Rating (5) in the Medical Specialties industry is significantly better than the same rating for CSTL (99) in the null industry. This means that VTAK’s stock grew significantly faster than CSTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLVTAK
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX112.13N/A
N/A
Franklin Biotechnology Discovery A
WLTTX11.55N/A
N/A
Wilshire International Equity Instl
RYCYX134.53N/A
N/A
Rydex Dow 2x Strategy C
JVARX38.26N/A
N/A
JPMorgan Value Advantage R5
DFUEX28.31-0.56
-1.94%
DFA US Social Core Equity 2 Portfolio

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with VCYT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-2.91%
VCYT - CSTL
39%
Loosely correlated
-4.17%
RDNT - CSTL
37%
Loosely correlated
-3.49%
TCMD - CSTL
36%
Loosely correlated
-5.29%
OFIX - CSTL
35%
Loosely correlated
-4.00%
BVS - CSTL
34%
Loosely correlated
-7.01%
More

VTAK and

Correlation & Price change

A.I.dvisor tells us that VTAK and PRPO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VTAK and PRPO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTAK
1D Price
Change %
VTAK100%
+7.90%
PRPO - VTAK
27%
Poorly correlated
+10.24%
BLFS - VTAK
25%
Poorly correlated
-3.16%
SGHT - VTAK
25%
Poorly correlated
-0.92%
CSTL - VTAK
25%
Poorly correlated
-2.91%
CERS - VTAK
25%
Poorly correlated
-6.72%
More